Advertisement
Advertisement

HIND

HIND logo

Vyome Holdings, Inc. Common Stock

2.25
USD
Sponsored
+0.04
+1.81%
Aug 11, 12:30 UTC -4
Open

Vyome Holdings, Inc. Common Stock Profile

About

Vyome Therapeutics Inc. is a clinical-stage healthcare company targeting immuno-inflammatory and rare diseases principally in the US. Vyome Therapeutics Inc., formerly known as ReShape Lifesciences Inc., is based in CAMBRIDGE, Mass.

Info & Links

CEO

Venkat Nelabhotla

Headquarters

Harvard Square, One Mifflin Place, Suite 400
Cambridge, MA 02138, UNITED STATES

Industry

Medical Drugs

Sector

Medical

Website

www.vyometx.com

Auditor

Kreit and Chiu CPA LLP

Share holders

13,200

Employees

18

Vyome Holdings, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

15.79M

Enterprise Value

7.00M

Enterprise Value/EBITDA(ttm)

-0.62

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

3.61

Price to Book(mrq)

1.89

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

50.22%

Operating Margin(ttm)

--

Profit Margin(ttm)

-6927.70%

Return on Equity(ttm)

-203.92%

Return on Invested Capital(ttm)

-249.04%

Return on Assets(ttm)

-134.16%

Income Statement

Revenue(ttm)

152.70K

Revenue Per Share(ttm)

0.02

Gross Profit(ttm)

81.00K

EBITDA(ttm)3

-11.37M

Net Income Available to Common(ttm)

-10.93M

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

1.48

52-Week Change

--

S&P 500 52-Week Change

21.42%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

7.02M

Dividend Yield

0.00%

Float4

4.70M

% Held by Insiders

33.00%

% Held by Institutions

22.06%

Balance Sheet

Total Cash(mrq)

8.80M

Total Cash Per Share(mrq)

1.25

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

4.27%

Quick Ratio(mrq)

4.27%

Book Value Per Share(mrq)

1.15

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.21

Free Cash Flow(ytd)

-1.44M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement